Buy CJC-1295

Buy CJC-1295 – CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, derived from the first 29 amino acids of human GHRH. Four targeted amino acid substitutions in the N-terminal section reduce cleavage by dipeptidyl peptidase IV. The variant with Drug Affinity Complex additionally carries a maleimide group that couples covalently to serum albumin in model systems, whereas the form without DAC – usually listed in the literature as Modified GRF (1-29) – lacks this binding site. Work in pituitary cell cultures and animal models examines how the GHRH receptor, a class B GPCR, signals through the cAMP/PKA pathway, how pulsatile versus sustained receptor occupancy modulates the somatotropic axis, and whether receptor desensitisation occurs. The side-by-side comparison of both variants makes the compound a useful tool for separating half-life concepts in model systems from receptor activation itself – an aspect that cannot be represented in the same way with ghrelin receptor agonists. Peptélia supplies it as a lyophilisate in a vial, with reconstitution and storage details on the product page; complementary compound classes are listed under Growth Factor Research. Each batch is tested in-house by HPLC and UV/Vis spectroscopy; the batch-specific certificate of analysis is available before purchase. For research use only. Not for use in or on the human body.